Dr. Tobi Nagel is Founder and President of Phages for Global Health, a non-profit organization that facilitates the application of phages in Africa and Asia, where roughly 90% of the deaths from antimicrobial resistance are expected to occur. Tobi previously spent 15 years in the pharmaceutical industry co-developing drugs that have been tested in >80 clinical trials. She was a Moonshot Fellow of the Kravis Lab for Social Impact, a Fulbright Specialist roster member, an Advisor to Phages for Human Applications Group Europe, and a founding Editorial Board member of the scientific journal PHAGE. She is currently an Advisory Board member for both the Phagebiotics Research Foundation and PhagePro, a company developing cholera phages. Tobi completed a PhD in Medical Engineering at the Harvard-MIT Division of Health Sciences and Technology and a BS in Chemical Engineering at Stanford University.